Formulations of biodegradable Nanogel carriers with 5′-triphosphates of nucleoside analogs that display a reduced cytotoxicity and enhanced drug activity
- 16 August 2007
- journal article
- research article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 121 (1-2), 19-27
- https://doi.org/10.1016/j.jconrel.2007.04.007
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Comparison of Nanogel Drug Carriers and their Formulations with Nucleoside 5′-TriphosphatesPharmaceutical Research, 2006
- A PEG‐Based Biocompatible Block Catiomer with High Buffering Capacity for the Construction of Polyplex Micelles Showing Efficient Gene Transfer toward Primary CellsChemMedChem, 2006
- Nanoscale polymer carriers to deliver chemotherapeutic agents to tumoursExpert Opinion on Biological Therapy, 2005
- Mechanisms of action of ribavirin against distinct virusesReviews in Medical Virology, 2005
- Cross-Linked Polymeric Nanogel Formulations of 5‘-Triphosphates of Nucleoside Analogues: Role of the Cellular Membrane in Drug ReleaseMolecular Pharmaceutics, 2005
- Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivativesThe Journal of Gene Medicine, 2005
- Nanogels for Oligonucleotide Delivery to the BrainBioconjugate Chemistry, 2003
- Block and Graft Copolymers and Nanogel™ Copolymer Networks for DNA Delivery into CellJournal of Drug Targeting, 2000
- Toxicity of Antiretroviral Nucleoside and Nucleotide AnaloguesDrug Safety, 2000
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990